Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2003
05/07/2003EP0957943B1 Matrix-free osteogenic devices, implants and methods of use thereof
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415366A Tincture for treating boils and its preparation method
05/07/2003CN1415364A Novel medical usage of yam rhizome dioscoreae septemlobae of Chinese traditional medicine and method for preparing its extractive
05/07/2003CN1415356A Medicament containing snail powder
05/07/2003CN1415344A Specific medicine of natural plants for curing sprain
05/07/2003CN1415342A Decoction of traditional Chinese drug for curing rheumatoid arthritis
05/07/2003CN1415331A Plaster for releasing ache of periarthritis humeroscapularis and its preparation method
05/07/2003CN1415291A Product for preventing and curing osteoporosis and its preparation method
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/07/2003CN1107525C Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for release of 17-ÔÇÿbeta'-estradiol to human organism
05/07/2003CN1107503C Optically pure compoun as medicinal use
05/06/2003US6559173 organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer,
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559142 Tricyclic substituted cyclic sulfonamides compound is useful for treating heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis
05/06/2003US6558905 Diagnosing osteoporosis in humans; obtain tissue sample, extract nucleotide sequences, digest, incubate with marker probe, detect presence of preferential allele, presence of allele indicate osteoporosis
05/06/2003CA2300663C Method for treating dysphagia
05/06/2003CA2244194C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/06/2003CA2109208C Radiolabeled metal-binding protein for the treatment of arthritis
05/02/2003EP1306368A2 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305050A2 Improved oral dosage formulations
05/02/2003EP1305046A2 Regulators of ppardelta (beta) and their use in the treatment of obesity and insulin resistance
05/02/2003EP1305032A1 Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
05/02/2003EP1305030A1 USE OF 2$g(a)-METHYL-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH
05/02/2003EP1305024A1 Method for treating fibrotic diseases or other indications ic
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1119351B1 Use of catechol derivatives as proteinase inhibitors
05/02/2003EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003EP1015423B1 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
05/02/2003EP0988035B1 Caspases and apoptosis
05/02/2003EP0948544B1 Monovalent antibody fragments
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0910563B1 Integrin receptor antagonists
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0724459B1 Formulations for delivery of osteogenic proteins
05/02/2003CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035654A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003WO2003035650A1 Entry inhibitor
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035640A1 Pyrimidone compounds and pharmaceutical compositions containing the same
05/01/2003WO2003035639A1 Pyrimidine compound and medicinal composition thereof
05/01/2003WO2003035638A1 4-imidazolin-2-one compounds
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035625A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035137A2 Method and apparatus for dispensing inhalator medicament
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035068A1 Macrolides containing pharmaceutical compositions
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035048A2 Methods for the treatment of osteoarthritis and compositions thereof
05/01/2003WO2003035037A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003WO2003035027A1 Chewable tablet containing lysine
05/01/2003WO2003035007A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
05/01/2003WO2003034995A2 Integrin targeting compounds
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003004008A3 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate
05/01/2003WO2003002109A8 Use of tyrosine kinase inhibitors for treating autoimmune diseases
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002100351A3 A method for treating inflammatory diseases by administering a ppar-delta agonist
05/01/2003WO2002099388A3 Benzodiazepine bradykinin antagonists
05/01/2003WO2002083734A3 Modified calcitonin
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002083151A3 Compositions and methods for treating an arthritic condition
05/01/2003WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002067866A3 Piperazine derivatives as metalloprotease inhibitors
05/01/2003WO2002059356A3 Method for screening compounds for activity in treating an osteoclast related bone disease
05/01/2003WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030083344 Tryptase inhibitors
05/01/2003US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083319 For treating osteoporosis, secondary hyperparathyroidism, cancer and autoimmune diseases without inducing hypercalciuria, hypercalcemia, or nephrotoxicity
1 ... 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 ... 820